According to J&J company McNeil Consumer Healthcare, the US pharma giant recalled 60,912 bottles of the drug after customers criticised the product’s scent, comparing it to that of mold.
The odor has been linked to the presence of trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA), a by-product of a preservative sometimes used on wooden shipping pallets.
McNeil insist the move was based on only a “small number” of complaints and added: “This voluntary action is being taken as a precaution and the risk of adverse medical events is remote.”
However experts are now pondering the safety of purchasing over-the-counter medicines from the J&J brand.
Curt Furgerg, a professor of public health sciences at Wake Forest Baptist Medical Center in Winston-Salem, N.C. said: “Clearly if a company has one recall, I could say 'Well, that's sort of an accident, just something that was very unfortunate.'
“But I think Johnson & Johnson has had it happen over and over and over again. They don't have their act together.”
When In-PharmaTechnologist contacted Media consultant for Tylenol, Bonnie Jacobs, she declined to provide further information on J&J’s recent influx of recalls, instead directing us to recent press releases on the Tylenol website.
Of the ten other recently recalled products, Tylenol released a statement on their website which read: “Separately, McNeil Consumer Healthcare is also adding ten lots of other products to a wholesale level recall it initiated on January 14, 2011.
“That recall did not require any action by consumers or healthcare providers and was not undertaken on the basis of adverse events.”